Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $3.8 million.

  • Niagen Bioscience's Net Cash Flow fell 1544.43% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 46696.89%. This contributed to the annual value of $17.3 million for FY2024, which is 15181.58% up from last year.
  • Per Niagen Bioscience's latest filing, its Net Cash Flow stood at $3.8 million for Q3 2025, which was down 1544.43% from $4.8 million recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Net Cash Flow peaked at $28.0 million during Q1 2021, and registered a low of -$7.2 million during Q1 2022.
  • In the last 5 years, Niagen Bioscience's Net Cash Flow had a median value of $552000.0 in 2023 and averaged $2.5 million.
  • Per our database at Business Quant, Niagen Bioscience's Net Cash Flow tumbled by 50057.42% in 2021 and then soared by 447208.33% in 2025.
  • Quarter analysis of 5 years shows Niagen Bioscience's Net Cash Flow stood at -$4.9 million in 2021, then surged by 247.02% to $7.2 million in 2022, then crashed by 92.31% to $552000.0 in 2023, then surged by 2121.38% to $12.3 million in 2024, then crashed by 68.88% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $4.8 million for Q2 2025, and $11.0 million during Q1 2025.